Phibro Animal Health Corporation (PAHC)

Debt-to-equity ratio

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 285,682 265,992 246,802 258,527 256,641 270,094 270,803 273,069 282,509 272,328 268,370 262,756 262,442 266,945 239,294 233,305 238,529 215,921 213,322 192,412
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

June 30, 2025 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $285,682K
= 0.00

The data indicates that Phibro Animal Health Corporation maintained a debt-to-equity ratio of zero across all recorded periods from September 30, 2020, through June 30, 2025. This consistent ratio suggests that the company did not utilize debt financing during this timeframe and relied entirely on equity to fund its operations and growth initiatives. Such a debt-free capital structure reflects a conservative financial stance, potentially minimizing financial risk and interest obligations. However, it also implies that the company may not have leveraged debt for expansion or operational enhancements, which can influence its return on equity and capacity for growth. Overall, the company's persistent zero debt-to-equity ratio signals a capital structure characterized by reliance solely on equity financing without leveraging debt.